Efficacy of obefazimod in ABTECT phase 3 induction trials: results of 8-week therapy in subsets of patients with and without prior inadequate response to advanced therapies

R Atreya, S Danese, B E Sands, L Peyrin-Biroulet, M Dubinsky, T Hisamatsu, H Tilg, B Siegmund, A Armuzzi, X Treton, F Baert, U Seidler, S Howaldt, F Cataldi, D Jacobstein, C J Rabbat, K Shan, G A Duvall, P S Dulai, D T Rubin, S Vermeire · Zeitschrift für Gastroenterologie · 2026 · Heft 08 · S. e320-e321